FDA inspection
Molecular PharmaGroup LLC: FDA inspection ending Dec 11, 2023
FDA inspection 1224590 · Voluntary Action Indicated (VAI) · New Providence, NJ
Key facts
| Inspection ID | 1224590 |
|---|---|
| Firm | Molecular PharmaGroup LLC |
| FEI number | 3014413265 |
| Address | 755 Central Ave Unit 2 |
| City | New Providence |
| State | NJ |
| ZIP | 07974 |
| Country | United States |
| Fiscal year | 2024 |
| Inspection end date | Dec 11, 2023 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data